SCHEMBL18503944

SCHEMBL18503944

c1ccc(-c2cccc(-c3cccc(-c4cccc(-c5cccc(-c6cc7ccccc7c(-c7ccccc7-c7ccccc7)n6)c5)c4)c3)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.40
ALDH1A1 P00352 4/20 0.40
MAPT P10636 4/20 0.40
HPGD P15428 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
MPI P34949 1/20 0.40
IDO1 P14902 1/20 0.39
TDO2 P48775 1/20 0.39
THRB P10828 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
TNF P01375 1/20 0.38
HSD17B1 P14061 1/20 0.38
HSD17B2 P37059 1/20 0.38
ACACA Q13085 2/20 0.38
ADORA3 P0DMS8 2/20 0.38
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18504000 0.98 KDM4E (0.39) KDM4EALDH1A1MAPTHPGDMEN1
SCHEMBL18504151 0.93 ALDH1A1 (0.47) KDM4EALDH1A1MAPTHPGDMEN1
SCHEMBL18504029 0.92 ALDH1A1 (0.46) KDM4EALDH1A1MAPTHPGDMEN1
SCHEMBL18504057 0.91 HSD17B1 (0.40) KDM4EALDH1A1MAPTHPGDMEN1
SCHEMBL18503938 0.91 KDM4E (0.40) KDM4EALDH1A1MAPTHPGDMEN1
SCHEMBL18503995 0.89 KDM4E (0.39) KDM4EALDH1A1MAPTHPGDMEN1
SCHEMBL18503942 0.87 KDM4E (0.45) KDM4EALDH1A1MAPTHPGDMEN1
SCHEMBL18503948 0.87 IDO1 (0.42) KDM4EALDH1A1MAPTHPGDMEN1
SCHEMBL18503969 0.87 CA12 (0.48) KDM4EALDH1A1MAPTHPGDMEN1
SCHEMBL18503997 0.85 CA12 (0.47) KDM4EALDH1A1MAPTHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10446764-B2 Organic compound, composition, organic optoelectric device, and display device SAMSUNG SDI CO., LTD. (KR) 2019-10-15 US disclosed
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-02-16 US disclosed
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10446764-B2 Organic compound, composition, organic optoelectric device, and display device OXER1, OCIAD1, OCIAD2 KDM4E 4289/4885ALDH1A1 129/4885MAPT 1518/4885
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE OXER1, OCIAD1, OCIAD2 KDM4E 4289/4885ALDH1A1 129/4885MAPT 1518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.